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Summary Propofol is associated with abnormal motor events resembling seizures,
the exact nature of these events remains to be elucidated. We describe here a case of
seizure-like activity after propofol-induced conscious sedation accompanied by a
prolactin rise, together suggesting that the event was ictal.
# 2008 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.Introduction
Sedation with propofol (Diprivan#) is now routine
for simple surgeries in the outpatient setting as it
produces rapid sedation with quick onset and offset.
The relatively few serious side effects (bradycardia,
subsequent asystole, hypotension, and dose-depen-
dent respiratory depression) have made propofol a
drug of choice for many procedures where general
anesthesia is not required. Several case reports,
reviews, and retrospective studies have noted
abnormal motor events resembling seizures asso-
ciated with propofol administration,1,2 but the nat-
ure of these events remains unclear. We report a
case of seizure-like activity with muscle aches dur-
ing emergence from propofol-induced conscious
sedation accompanied by a prolactin rise, together
suggesting that the event was ictal and not synco-
pal, a movement disorder or psychogenic.* Corresponding author. Tel.: +1 410 955 6626.
E-mail address: steven.zeiler@jhmi.edu (S.R. Zeiler).
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A 51-year-old, previously well woman was con-
sciously sedated for 90 min with a bolus of propofol
150 mg IV followed by propofol 6.5 mg/(kg h)
(total dose = 1016 mg IV), fentanyl 100 mcg IV,
and lidocaine 10 ml subcutaneously during a meta-
tarsal bone graft repair. In the recovery room, the
patient’s arms were seen to extend tonically fol-
lowed by rhythmic shaking for approximately 3 min;
the patient was unresponsive to verbal or physical
stimulus throughout. She was treated with loraze-
pam 2 mg IV. After several minutes, a second similar
tonic—clonic event occurred and the patient was
given lorazepam 2 mg IV and phenytoin 15 mg/kg.
The patient had no memory of the events. Prior to
admission, the patient had taken no medications,
had no known illnesses, had no knowledge of any
familial neurological diseases, and refrained from
alcohol and illicit substance use.
Physical examination after the spell revealed a
groggy but otherwise normal woman with no neu-
rological signs. She complained of muscle aches.
Electrolytes, liver function tests, complete blood. Published by Elsevier Ltd. All rights reserved.
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all normal. EEG approximately 1 h after the
spells was normal. MR imaging was also unremark-
able. There was an elevated prolactin level at
35.4 ng/ml (normal range: 0—18 ng/ml) 25 min
after her second spell. There were no further
spells. The patient was discharged home with no
medications.Discussion
Several case reports and reviews have reported a
correlation between propofol administration and
abnormal motor events. These events have vari-
ably been attributed to dystonia, clonus, oculo-
gyric crisis, opisthotonos, or choreoathetosis,1,2
but further clarifying evidence to distinguish
among these possibilities was absent. Although
many of these abnormal motor events resemble
seizures (hence the term ‘‘seizure-like epi-
sodes’’), there has been no report of simultaneous
EEG recordings of cortical epileptic activity during
such motor events.1 Further, systematic studies in
both humans and animals strongly suggest that
propofol possesses antiepileptic properties (for
example, Ref. 3). Thus, speculation as to these
events’ true etiology has led some authors to
postulate exaggerated spontaneous and involun-
tary movements similarly seen with other anes-
thetic agents.4
Evidence supporting an ictal diagnosis in our case
is the following. First, the resemblance of the move-
ments to a tonic—clonic pattern reported here and
elsewhere1,2 suggest seizure activity. Second, pro-
pofol may antagonizes inhibitory neurotransmitters,
particularly glycine,5 at lower doses. This corre-
sponds with one of the principal findings of the
largest systematic reviews analyzing seizure-like
episodes and propofol: seizure-like episodes occur
during induction or emergence and not during main-
tenance of anesthesia.1 Although these results could
be explained by the fact that maintenance of
anesthesia is usually associated with no change in
the conscious state and thus probably less cerebral
excitation, a substrate for seizures, these results
are also consistent with the hypothesis that low
doses of propofol may be centrally excitatory. Alter-
natively, propofol may also act by depressing sub-
cortical inhibitory centers6 thus resulting in cortical
excitation producing seizures7 as well as other
movements.
Finally, in our patient, there was an elevated
prolactin level within 30 min of the patient’s spell–—
an event heretofore not reported. Prolactin levels
frequently rise after a single complex partial orsecondarily generalized seizures8 as it did in our
patient. Prolactin levels are not elevated after
psychogenic nonepileptic seizures; they have not
been studied after acute dystonias or dyskinesias.9
Nevertheless, there are several caveats that pre-
vent this prolactin elevation from definitively sug-
gesting that our patient experienced a seizure.
First, prolactin may rise after syncope.10 Second,
although propofol in low doses (approximately
1 mg/(kg h)) does not raise prolactin levels,11
higher doses may (for example, Ref. 12). However,
we suggest that the clinical constellation of post-
event muscle aches, more prolonged amnesia and
confusion, and the occurrence of two stereotyped
events, along with a rise in prolactin are far more
supportive of a seizure than of syncope or another
explanation.13
In the controversy on the nature of seizure-like
events after propofol administration, we believe
that this case with clear pattern of ictal clinical
features along with a raised prolactin level helps
resolve the issue in favor of an acute reactive
seizure.Acknowledgements
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